In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
Archival photo of Maria Jasin and Mary Ellen Moynahan
From Breaks to Breakthroughs

Maria Jasin’s discoveries have led to concrete advances in patient care. The targeted medicines called PARP inhibitors, for example, are based on knowledge gained from her work.
Albert Kuchler with MSK medical oncologist Bob Li.
Harnessing the Power of Data for Patient Care

Computational biology is helping to bring predictive power and precision to oncology.
Ming Li
How One Lab at MSK Is Working To Harness the Power of the Immune System Against Cancer

Study by study, Dr. Ming Li's lab at MSK is sharing new insights into the molecular and cellular mechanisms involved in immune regulation.
Black-and-white microscopic image of cell from human granular cell tumor
In the Lab
A Study of Rare Tumors Uncovers the Presence of Tumor-Suppressing Genes

Studying the genes of granular cell tumors has revealed a previously unknown process through which cells can turn cancerous.
An illustration of a magnifying glass over a brain.
Finding
Study Reveals a New Way That Stress and Aging Lead to Alzheimer’s

A targeted approach being developed to treat certain cancers may also be effective for Alzheimer’s disease.
An MSK scientist pipettes in the lab
MSK Research Highlights, May 18, 2023

New MSK research shows how high-risk neuroblastoma evolves to be so deadly; finds continued safety and efficacy for sotorasib in patients with KRAS G12C-mutated advanced non-small cell lung cancer; and demonstrates promise in eradicating tumors by delivering a viral-based immunotherapeutic to melanoma and breast cancer in mouse models.
Pictured: Kenneth Offit
In the Lab
Gene Mutation Linked to Inherited Risk of Common Form of Childhood Leukemia

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
MSK gynecologic surgeon Dr. Mario Leitao and Dr. Anh Le.
Patient Story
Full Circle: MSK Patient Survives Deadly Cervical Cancer and Returns to Train as Doctor

Read about a medical student treated at MSK for aggressive cervical cancer who later returned to train alongside MSK surgeons.
Reicy Bobadilla stands in front of a window with the MSK logo on it
What You Should Know About Mesothelioma in Younger Patients

A new study is challenging the perception that mesothelioma affects only older men. Learn why MSK experts say the medical community should be aware of this rare cancer's early symptoms.
MSK Researchers Look for Answers That May Lead to Advances in Treating Leptomeningeal Metastasis, a Virtually Untreatable Complication

Leptomeningeal metastasis, cancer that has spread to the areas surrounding the brain and spinal cord, has long been a formidable clinical challenge for oncologists. Researchers at Memorial Sloan Kettering Cancer Center have identified the molecular basis of this increasingly prevalent complication of cancer. With the help of a mouse model, researchers have identified a drug strategy that may combat this virtually untreatable condition. This research by Joan Massagué, PhD, Adrienne Boire, MD, PhD, and colleagues, was published in the March 9, 2017 issue of Cell. For more information on this work and to speak with the study authors, contact [email protected].